Metalloproteinases and their roles in human cancer

R Roy, G Morad, A Jedinak… - The Anatomical Record, 2020 - Wiley Online Library
It is now widely appreciated that members of the matrix metalloproteinase (MMP) family of
enzymes play a key role in cancer development and progression along with many of the …

ADAM proteases: emerging role and targeting of the non-catalytic domains

N Saha, D Robev, JP Himanen, DB Nikolov - Cancer letters, 2019 - Elsevier
ADAM proteases are multi domain transmembrane metalloproteases that cleave a range of
cell surface proteins and activate signaling pathways implicated in tumor progression …

Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis

SE Di Carlo, J Raffenne, H Varet, A Ode… - Nature …, 2023 - nature.com
The capacity to survive and thrive in conditions of limited resources and high inflammation is
a major driver of tumor malignancy. Here we identified slow-cycling ADAM12+ PDGFRα+ …

Matricellular protein SPARCL1 regulates tumor microenvironment–dependent endothelial cell heterogeneity in colorectal carcinoma

E Naschberger, A Liebl, VS Schellerer… - The Journal of …, 2016 - Am Soc Clin Investig
Different tumor microenvironments (TMEs) induce stromal cell plasticity that affects
tumorigenesis. The impact of TME-dependent heterogeneity of tumor endothelial cells …

[HTML][HTML] Genes associated with bowel metastases in ovarian cancer

A Mariani, C Wang, AL Oberg, SM Riska, M Torres… - Gynecologic …, 2019 - Elsevier
Objective This study is designed to identify genes and pathways that could promote
metastasis to the bowel in high-grade serous ovarian cancer (OC) and evaluate their …

Epithelial/mesenchymal heterogeneity of high‐grade serous ovarian carcinoma samples correlates with miRNA let‐7 levels and predicts tumor growth and metastasis

E Chirshev, N Hojo, A Bertucci… - Molecular …, 2020 - Wiley Online Library
Patient‐derived samples present an advantage over current cell line models of high‐grade
serous ovarian cancer (HGSOC) that are not always reliable and phenotypically faithful …

Upregulation of ADAM12 is associated with a poor survival and immune cell infiltration in colon adenocarcinoma

Z Huang, H Lai, J Liao, J Cai, B Li, L Meng… - Frontiers in …, 2021 - frontiersin.org
Background A disintegrin and metalloprotease 12 (ADAM12) is a member of the
multidomain protein family, but the mechanisms by which it affects prognosis and immune …

ADAM12 is a novel regulator of tumor angiogenesis via STAT3 signaling

R Roy, A Dagher, C Butterfield, MA Moses - Molecular Cancer Research, 2017 - AACR
Abstract ADAM12,(AD isintegrin a nd m etalloproteinase domain-containing protein 12), is
upregulated in epithelial cancers and contributes to increased tumor proliferation …

[HTML][HTML] Research progress in prognostic factors and biomarkers of ovarian cancer

S Liu, M Wu, F Wang - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Ovarian cancer is a serious threat to women's health; its early diagnosis rate is low and
prone to metastasis and recurrence. The current conventional treatment for ovarian cancer is …

Adenosine receptor A2B negatively regulates cell migration in ovarian carcinoma cells

AR Campos-Contreras, A González-Gallardo… - International Journal of …, 2022 - mdpi.com
The purinergic system is fundamental in the tumor microenvironment, since it regulates
tumor cell interactions with the immune system, as well as growth and differentiation in …